Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Other

A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery

Colon Cancer

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcome: Primary: Overall Time for Dissection of the Soft Tissues — 91; 77 minutes — p=0.214

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
THUNDERBEAT (Device); LIGASURE (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Weill Medical College of Cornell University
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Time for Dissection of the Soft Tissues
91; 77 0.214
PRIMARY
Versatility Score
4.8; 4.7 0.007 sig
SECONDARY
Length of Post Surgical Stay in the Hospital
4.5; 5.3
SECONDARY
Dryness of the Surgical Field Average Score Mean/sd
4.5; 4.4
SECONDARY
Intraoperative Complication Related to the Energy Devices
0; 0
SECONDARY
Delayed Thermal Injuries Related to Energy Devices
0; 0 1.0
SECONDARY
Operative Procedure Time
176; 170

Summary

Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2 - Ligasure Population

Eligibility Criteria

Inclusion Criteria

  • Patients that will be undergoing a Left Laparoscopic Colon Resection
  • Older than 18 years old
  • ASA 1 to 3
  • Elective surgeries
  • Patients who willingly provide informed consent

Exclusion Criteria

  • Morbidly obese patients (BMI >35)
  • Patients with acute diverticulitis
  • Patients with multiple previous abdominal surgeries
  • Patients on anticoagulants
  • Patients who can not, tolerate a major surgery
  • Patients for whom electrosurgery is contraindicated
  • Patients who are pregnant
  • Patient with IBDs
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02628093). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search